111, Inc. (YI): Price and Financial Metrics
GET POWR RATINGS... FREE!
YI POWR Grades
- YI scores best on the Sentiment dimension, with a Sentiment rank ahead of 83.05% of US stocks.
- YI's strongest trending metric is Value; it's been moving up over the last 161 days.
- YI ranks lowest in Growth; there it ranks in the 14th percentile.
YI Stock Summary
- 111 Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 0.17% of US listed stocks.
- With a price/sales ratio of 0.18, 111 Inc has a higher such ratio than merely 2.01% of stocks in our set.
- YI's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 97.95% of US stocks.
- If you're looking for stocks that are quantitatively similar to 111 Inc, a group of peers worth examining would be COMM, BGI, ORLY, MKD, and HCA.
- Visit YI's SEC page to see the company's official filings. To visit the company's web site, go to www.111.com.cn.
YI Stock Price Chart Interactive Chart >
YI Price/Volume Stats
| Current price | $3.17 | 52-week high | $45.88 |
| Prev. close | $3.14 | 52-week low | $2.78 |
| Day low | $3.16 | Volume | 366,530 |
| Day high | $3.54 | Avg. volume | 218,187 |
| 50-day MA | $3.75 | Dividend yield | N/A |
| 200-day MA | $6.87 | Market Cap | 262.09M |
111, Inc. (YI) Company Bio
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. It also offers a suite of cloud-based solutions and Internet-based software services, including the provision of access to business applications and service modules, such as customer relationship management, supply chain management, online medical consultation, e-prescriptions, digital contract sales organization, and precision marketing. In addition, the company is involved in warehousing, logistics, procurement, research and development, and consulting activities; and software development and information technology support businesses. As of June 30, 2018, 111, Inc. had a network of 12 offline retail pharmacies branded as Yi Hao Pharmacy in Guangzhou, Shanghai, Tianjin, and Kunshan. It services pharmacies, pharmaceutical companies, medical professionals and consumers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2012 and is based in Shanghai, China.
Latest YI News From Around the Web
Below are the latest news stories about 111 Inc that investors may wish to consider to help them evaluate YI as an investment opportunity.
Further weakness as 111 (NASDAQ:YI) drops 11% this week, taking three-year losses to 51%If you love investing in stocks you're bound to buy some losers. Long term 111, Inc. ( NASDAQ:YI ) shareholders know... |
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. |
/C O R R E C T I O N -- 111, Inc./In the news release, 111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to Follow, issued 28-Oct-2021 by 111, Inc. over PR Newswire, we are advised by the company that the 2nd paragraph in the brackets, should read " 8:30 PM Beijing Time on the same day " rather than "7:30 PM Beijing Time on the same day" as originally issued inadvertently. The complete, corrected release follows: |
111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to FollowSHANGHAI, Oct. 28, 2021 /PRNewswire/ – 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2021, before the U.S. market opens on Friday, November 19, 2021. |
111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced a strategic cooperation agreement with Chugai Pharma China Co., Ltd. ("Chugai Pharma China"). |
YI Price Returns
| 1-mo | -6.76% |
| 3-mo | -43.09% |
| 6-mo | -53.86% |
| 1-year | -58.40% |
| 3-year | -57.90% |
| 5-year | N/A |
| YTD | -9.43% |
| 2021 | -49.64% |
| 2020 | 3.27% |
| 2019 | 9.61% |
| 2018 | N/A |
| 2017 | N/A |
Continue Researching YI
Want to do more research on 111 Inc's stock and its price? Try the links below:111 Inc (YI) Stock Price | Nasdaq
111 Inc (YI) Stock Quote, History and News - Yahoo Finance
111 Inc (YI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...